Hormone replacement therapy [topp]
postmenopausal [tmco]
Woman [popg]
Epilepsy [dsyn]
Objective [inpr]
Evaluate [ftcn]
effects [qlco]
Hormone replacement therapy [topp]
Seizure activity [fndg]
postmenopausal [tmco]
Woman [popg]
Epilepsy [dsyn]
postmenopausal [tmco]
Women [popg]
Increased [qnco]
Cardiovascular disease [dsyn]
Osteoporosis [dsyn]
secondary [neop]
lack [qlco]
Estrogen Effects [fndg]
Women [popg]
Known [qlco]
contraindications [qlco]
Often [tmco]
Take [hlca]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Epilepsy [dsyn]
Osteoporosis [dsyn]
Negative [qlco]
Certain [qlco]
Antiepileptic Drugs [phsu]
Bone Density [clna]
Clinical Studies [resa]
experience [menp]
Hormonal [qlco]
Variance [qlco]
Woman [popg]
Play [dora]
Seizure activity [fndg]
effects [qlco]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Epilepsy [dsyn]
Unknown [qlco]
summary [inpr]
Report [inpr]
Old [tmco]
postmenopausal [tmco]
White [popg]
Woman [popg]
Epilepsy [dsyn]
Presented [idcn]
Vasomotor [ftcn]
Flushing [sosy]
effects [qlco]
Hormone replacement therapy [topp]
Seizure activity [fndg]
therapy [ftcn]
Initiate [idcn]
Phases [tmco]
Monthly [tmco]
Evaluation [ftcn]
Weekly Transdermal Patch [medd]
Estradiol [horm, phsu, strd]
mg/d [qnco]
Initiate [idcn]
months [tmco]
Second [qnco]
months [tmco]
Regimen [topp]
expanded [spco]
Oral [spco]
medroxyprogesterone acetate 2.5 MG [clnd]
Daily [tmco]
Anti-epileptic [phsu]
Medications [phsu]
Dosages [qnco]
Hormone replacement therapy [topp]
Decreased [qnco]
Seizures [sosy]
Cessation [acty]
Vasomotor [ftcn]
Flushing [sosy]
Improved [qlco]
Sleep [orgf]
IMPACT [gngm]
Lipid [lipd]
Profile [lbpr]
Conclusions [idcn]
case report [inpr]
prospective [resa]
Addition [ftcn]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Woman [popg]
Epilepsy [dsyn]
Suggest [idcn]
Hormone replacement therapy [topp]
Initiate [idcn]
Certain [qlco]
Women [popg]
Therapeutic [topp]
Benefits [qnco]
Affecting [ftcn]
Seizure activity [fndg]
